Once-Daily Oral Semaglutide Versus Injectable Glp 1 RAs in People With Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-Analysis
posted on 2021-03-05, 12:29authored byAdis journals on behalf of, Barrie Chubb, Palvi Gupta, Jatin Gupta, Solomon Nuhoho, Klaus Kallenbach, Michelle Orme
Article full
text
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).